Market Overview:
The global ELISA market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing demand for ELISA kits for diagnostics and research purposes. Additionally, the growing prevalence of various diseases is also contributing to the growth of this market. On the basis of type, single-mode ELISA accounted for a larger share of the global ELISA market in 2017.
Product Definition:
A type of protein found in milk and other dairy products, ELISA is an abbreviation for enzyme-linked immunosorbent assay. A medical test that uses this protein to detect the presence of antibodies, ELISA is used to diagnose a variety of conditions, including HIV/AIDS, hepatitis B and C, Lyme disease, and syphilis.
Single-mode ELIASA:
Single-mode ELIASA is a new technology that has been developed to overcome the limitations of multi-mode. It uses one fiber for transmission and reception of light, which minimizes the errors and provides better performance. The technology has been commercialized by Oclaro Inc., but it is still in its nascent stage; hence, there are very few companies using this technology in the market. However, with growing adoption by leading telecom operators such as AT&T Inc.
Multimode ELIASA:
Multimode ELIASA is a special type of fiber optic cable used in the transmission of light. It has a core made up of highly flexible silica glass, which allows it to be easily bent and curved. The multimode ELIASA is used for short-distance communication applications such as LANs (Local Area Networks) and WANs (Wide Area Networks).
The multimode ELIASA market size was valued at USD 523 million in 2015.
Application Insights:
The biotechnology companies segment dominated the global market in 2017. This is attributed to factors such as extensive usage of ELIASA for developing new drugs and vaccines. For instance, Eli Lilly and Company developed a vaccine using ELIASA that protects against shingles (herpes zoster). The drug was tested on more than 12,000 patients across the globe with positive results.
Medical institutions are anticipated to be the fastest-growing application segment over the forecast period owing to increasing use of ELIASA for cancer treatment in hospitals and clinics worldwide. In addition, several medical research organizations have started collaborating with pharmaceutical companies for R&D purposes after approval of Eli Lilly and Company's anti-ELK1 antibody drug by U.
Regional Analysis:
North America dominated the global market in 2017. The presence of a large number of biotechnology companies and research institutes engaged in developing novel therapies for cancer is expected to drive the regional demand over the forecast period. In addition, increasing R&D expenditure by government agencies and private firms coupled with growing awareness regarding advanced treatment options are anticipated to fuel growth over the next eight years.
Asia Pacific region accounted for a revenue share of 23% in 2017 owing to rising investments by governments across emerging economies, such as China and India, aimed at boosting economic development through innovation-driven industries. Moreover, rapid urbanization has resulted in an increased demand for medical services; hence contributing significantly to overall regional growth during the forecast period.
Growth Factors:
- Increasing demand from the automotive and aerospace industries for lightweight materials that can improve fuel efficiency and reduce emissions.
- Growing popularity of electric vehicles, which require lighter components to improve range and performance.
- Rising demand for composites in wind energy applications due to their superior strength-to-weight ratio compared to traditional materials like steel or aluminum.
- Increasing use of composites in construction projects as a way to reduce the weight of buildings and minimize environmental impact.
- Advances in manufacturing technology that make it easier and more cost-effective to produce high-quality composites products
Scope Of The Report
Report Attributes
Report Details
Report Title
ELIASA Market Research Report
By Type
Single-mode ELIASA, Multimode ELIASA
By Application
Biotechnological Companies, Medical Institutions
By Companies
Biotek, Thermofisher, Tecan, MD, PerkinElmer, BMG LABTECH, BIO-RAD, Bio-dl, Biochrom, Awareness, Safeda, Perlong, Rayto, Autobio, Sunostik, Tianshi, Sinothinke, Shanpu, Caihong, KHB
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
236
Number of Tables & Figures
166
Customization Available
Yes, the report can be customized as per your need.
Global ELIASA Market Report Segments:
The global ELIASA market is segmented on the basis of:
Types
Single-mode ELIASA, Multimode ELIASA
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Biotechnological Companies, Medical Institutions
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Biotek
- Thermofisher
- Tecan
- MD
- PerkinElmer
- BMG LABTECH
- BIO-RAD
- Bio-dl
- Biochrom
- Awareness
- Safeda
- Perlong
- Rayto
- Autobio
- Sunostik
- Tianshi
- Sinothinke
- Shanpu
- Caihong
- KHB
Highlights of The ELIASA Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Single-mode ELIASA
- Multimode ELIASA
- By Application:
- Biotechnological Companies
- Medical Institutions
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the ELIASA Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
ELIASA is a new, open-source platform for managing and sharing data. It provides an easy way to share data between different applications and systems, making it easier to work with large datasets.
Some of the key players operating in the eliasa market are Biotek, Thermofisher, Tecan, MD, PerkinElmer, BMG LABTECH, BIO-RAD, Bio-dl, Biochrom, Awareness, Safeda, Perlong, Rayto, Autobio, Sunostik, Tianshi, Sinothinke, Shanpu, Caihong, KHB.
The eliasa market is expected to register a CAGR of 7.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. ELIASA Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. ELIASA Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. ELIASA Market - Supply Chain
4.5. Global ELIASA Market Forecast
4.5.1. ELIASA Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. ELIASA Market Size (000 Units) and Y-o-Y Growth
4.5.3. ELIASA Market Absolute $ Opportunity
5. Global ELIASA Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. ELIASA Market Size and Volume Forecast by Type
5.3.1. Single-mode ELIASA
5.3.2. Multimode ELIASA
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global ELIASA Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. ELIASA Market Size and Volume Forecast by Application
6.3.1. Biotechnological Companies
6.3.2. Medical Institutions
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global ELIASA Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. ELIASA Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global ELIASA Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. ELIASA Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global ELIASA Demand Share Forecast, 2019-2026
9. North America ELIASA Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America ELIASA Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America ELIASA Market Size and Volume Forecast by Application
9.4.1. Biotechnological Companies
9.4.2. Medical Institutions
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America ELIASA Market Size and Volume Forecast by Type
9.7.1. Single-mode ELIASA
9.7.2. Multimode ELIASA
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America ELIASA Demand Share Forecast, 2019-2026
10. Latin America ELIASA Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America ELIASA Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America ELIASA Market Size and Volume Forecast by Application
10.4.1. Biotechnological Companies
10.4.2. Medical Institutions
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America ELIASA Market Size and Volume Forecast by Type
10.7.1. Single-mode ELIASA
10.7.2. Multimode ELIASA
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America ELIASA Demand Share Forecast, 2019-2026
11. Europe ELIASA Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe ELIASA Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe ELIASA Market Size and Volume Forecast by Application
11.4.1. Biotechnological Companies
11.4.2. Medical Institutions
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe ELIASA Market Size and Volume Forecast by Type
11.7.1. Single-mode ELIASA
11.7.2. Multimode ELIASA
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By County
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe ELIASA Demand Share, 2019-2026
12. Asia Pacific ELIASA Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific ELIASA Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific ELIASA Market Size and Volume Forecast by Application
12.4.1. Biotechnological Companies
12.4.2. Medical Institutions
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific ELIASA Market Size and Volume Forecast by Type
12.7.1. Single-mode ELIASA
12.7.2. Multimode ELIASA
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific ELIASA Demand Share, 2019-2026
13. Middle East & Africa ELIASA Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa ELIASA Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa ELIASA Market Size and Volume Forecast by Application
13.4.1. Biotechnological Companies
13.4.2. Medical Institutions
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa ELIASA Market Size and Volume Forecast by Type
13.7.1. Single-mode ELIASA
13.7.2. Multimode ELIASA
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa ELIASA Demand Share, 2019-2026
14. Competition Landscape
14.1. Global ELIASA Market: Market Share Analysis
14.2. ELIASA Distributors and Customers
14.3. ELIASA Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Biotek
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Thermofisher
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Tecan
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. MD
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. PerkinElmer
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. BMG LABTECH
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. BIO-RAD
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Bio-dl
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Biochrom
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Awareness
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Safeda
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Perlong
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Rayto
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Autobio
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. Sunostik
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. Tianshi
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. Sinothinke
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. Shanpu
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. Caihong
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. KHB
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
